Showing 1 - 6 results of 6 for search 'Sandro Pignata', query time: 0.01s Refine Results
  1. 1
    Patient and public involvement in research: a survey on experience, opinions and training needs of gynecologic oncologists in two collaborative groups in Italy

    Patient and public involvement in research: a survey on experience, opinions and training needs of gynecologic oncologists in two collaborative groups in Italy by Cinzia Colombo, Pasquale Paletta, Antonella Savarese, Sandro Pignata, Paola Mosconi, Elena Biagioli

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy

    Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy by Ernesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, Flaviano Di Paola, Monica Cantile, Sabrina Chiara Cecere, Sandro Pignata, Alessandro Morabito, Raffaele Costanzo, Massimo Di Maio, Francesco Perrone

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor: A tertiary care experience

    Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor: A tertiary care experience by Dario Franzese, Antonio Tufano, Alessandro Izzo, Raffaele Muscariello, Giovanni Grimaldi, Giuseppe Quarto, Luigi Castaldo, Sabrina Rossetti, Savio Domenico Pandolfo, Sonia Desicato, Paola Del Prete, Matteo Ferro, Sandro Pignata, Sisto Perdonà

    Published 2023-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells.

    The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. by Daniela Russo, Anna Spina, Luigi Portella, Anna Maria Bello, Francesca Galdiero, Anna Maria Trotta, Caterina Ieranò, Giuseppina Rea, Sabrina Chiara Cecere, Elisabetta Coppola, Salvatore Di Maro, Sandro Pignata, Daniela Califano, Stefania Scala

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study

    Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study... by Francesca Basso‐Valentina, Vincenzo Canzonieri, Rossella De Cecio, Laura Arenare, Domenica Lorusso, Sabrina Chiara Cecere, Eliana Pivetta, Daniela Russo, Annabella Di Mauro, Grazia Artioli, Anna Spina, Carmine De Angelis, Daniela Califano, Saverio Cinieri, Giosuè Scognamiglio, Vanda Salutari, Paolo Chiodini, Francesco Perrone, Sandro Pignata, Gustavo Baldassarre

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers

    Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers by Giulia Scotto, Anna Galatà, Robert Fruscio, Robert Fruscio, Giulia Besana, Fabio Landoni, Fabio Landoni, Luca Sgro, Alessandra Testi, Fulvio Borella, Gennaro Cormio, Gennaro Cormio, Mariangela Gianciotta, Mariangela Gianciotta, Francesca Arezzo, Francesca Arezzo, Brigida Anna Maiorano, Alessandra Baldoni, Marinella Destefanis, Jole Ventriglia, Sandro Pignata, Rita Chiari, Maria Carmen Azzolina, Ivano Raimondo, Ivano Raimondo, Margherita Turinetto, Valentina Tuninetti, Massimo Di Maio, Giorgio Valabrega

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: